Skip to main content Accessibility help
  • Print publication year: 2012
  • Online publication date: January 2013

Chapter 3 - Sleep apnea, autonomic dysfunction, and vascular diseases


1. YoungT, PaltaM, DempseyJ, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230–5.
2. LugaresiE, CirignottaF, CoccagnaG, et al. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 1980; 3: 221–4.
3. PartinenM, GuilleminaultC. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97: 27–32.
4. YoungT, ShaharE, NietoFJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162: 893–900.
5. NietoFJ, YoungTB, LindBK, et al. Association of sleep disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829–36.
6. PeppardPE, YoungT, PaltaM, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–84.
7. LavieP, HererP, HoffsteinV. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479–82.
8. SomersVK, WhiteDP, AminR, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008; 52: 686–717.
9. BassettiC, AldrichMS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999; 22: 217–23.
10. YaggiHK, ConcatoJ, KernanWN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034–41.
11. FletcherEC. An animal model of the relationship between systemic hypertension and repetitive episodic hypoxia as seen in sleep apnoea. J Sleep Res 1995; 4: 71–7.
12. FlectcherEC. Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 2001; 90: 1600–5.
13. LugaresiE, CoccagnaG, MantovaniM, et al. Some periodic phenomena arising during drowsiness and sleep in man. Electroencephalogr Clin Neurophysiol 1972; 32: 701–5.
14. ConwayJ, BoonN, JonesJV, et al. Involvement of the baroreceptor reflexes in the changes in blood pressure with sleep and mental arousal. Hypertension 1983; 5: 746–8.
15. ManciaG. Autonomic modulation of the cardiovascular system during sleep. N Engl J Med 1993; 328: 347–9.
16. LugaresiE, ProviniF, CortelliP. Sleep embodies maximum and minimum levels of autonomic integration. Clin Auton Res 2001; 11: 5–10.
17. BraunAR, BalkinTJ, WesensteinNJ, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H20 150 PET study. Brain 1997; 120: 1173–97.
18. ParmeggianiPL, FranziniC. Changes in the activity of hypothalamic units during sleep at different environmental temperatures. Brain Res 1971; 29: 347–50.
19. BuguetAC, LivingstoneSD, ReedLD, et al. EEG patterns and body temperatures in man during sleep in arctic winter nights. Int J Biometeorol 1976; 20: 61–9.
20. CoccagnaG, MantovaniM, BrignaniF, et al. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 1972; 8: 1159–72.
21. LugaresiE, CoccagnaG, MantovaniM, et al. Hypersomnia with periodic breathing: periodic apneas and alveolar hypoventilation during sleep. Bull Physiopathol Respir (Nancy) 1972; 8: 1103–13.
22. CortelliP, PierangeliG, ProviniF, et al. Blood pressure rhythms in sleep disorders and dysautonomia. Ann N Y Acad Sci 1996; 783: 204–21.
23. PortaluppiF, ProviniF, CortelliP, et al. Undiagnosed sleep-disordered breathing in male nondippers with essential hypertension. J Hypertens 1997; 15: 1227–33.
24. PortaluppiF, TiseoR, SmolenskyMH, et al. Circadian rhythms and cardiovascular health. Sleep Med Rev 2012; 16: 151–66.
25. KalesA, BixlerEO, CadieuxRJ, et al. Sleep apnoea in a hypertensive population. Lancet 1984; 2: 1005–8.
26. NodaA, YasumaF, OkadaT, et al. Circadian rhythm of autonomic activity in patients with obstructive sleep apnea syndrome. Clin Cardiol 1998; 21: 271–6.
27. CortelliP, ParchiP, SforzaE, et al. Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome. Clin Auton Res 1994; 4: 57–62.
28. HargensTA, GuillSG, ZedalisD, et al. Attenuated heart rate recovery following exercise testing in overweight young men with untreated obstructive sleep apnea. Sleep 2008; 31: 104–10.
29. VanninenE, TuunainenA, KansanenM, et al. Cardiac sympathovagal balance during sleep apnea episodes. Clin Physiol 1996; 16: 209–16.
30. WangW, TretriluxanaS, RedlineS, et al. Association of cardiac autonomic function measures with severity of sleep-disordered breathing in a community-based sample. J Sleep Res 2008; 17: 251–62.
31. MéndezMO, CorthoutJ, Van HuffelS, et al. Automatic screening of obstructive sleep apnea from the ECG based on empirical mode decomposition and wavelet analysis. Physiol Meas 2010; 31: 273–89.
32. NodaA, NakataS, KoikeY, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 2007; 30: 669–76.
33. BaguetJP, NarkiewiczK, MallionJM. Update on hypertension management: obstructive sleep apnea and hypertension. J Hypertens 2006; 24: 205–8.
34. FriedmanO, LoganAG. The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects. Am J Hypertens 2009; 22: 474–83.
35. WatanabeT, ManoT, IwaseS, et al. Enhanced muscle sympathetic nerve activity during sleep apnea in the elderly. J Auton Nerv Syst 1992; 37: 223–6.
36. DonadioV, LiguoriR, VetrugnoR, et al. Parallel changes in resting muscle sympathetic nerve activity and blood pressure in a hypertensive OSAS patient demonstrate treatment efficacy. Clin Auton Res 2006; 16: 235–9.
37. CaplesSM, Garcia-TouchardA, SomersVK. Sleep-disordered breathing and cardiovascular risk. Sleep 2007; 30: 291–304.
38. PrabhakarNR, DickTE, NanduriJ, et al. Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp Physiol 2007; 92: 39–44.
39. BrooksD, HornerRL, KozarLF, et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106–9.
40. NarkiewiczKC, PesekA, KatoM, et al. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 1998; 32: 1039–43.
41. BonsignoreMR, ParatiG, InsalacoG, et al. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166: 279–86.
42. BonsignoreMR, ParatiG, InsalacoG, et al. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J 2006; 27: 128–35.
43. LombardiC, ParatiG, CortelliP, et al. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res 2008; 17: 263–70.
44. ParatiG, LombardiC, NarkiewiczK. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol 2007; 293: R1671–83.
45. PrabhakarNR, KumarGK, NanduriJ. Intermittent hypoxia-mediated plasticity of acute O2 sensing requires altered redox regulation by HIF-1 and HIF-2. Ann N Y Acad Sci 2009; 1177: 162–8.
46. CarlsonJT, HednerJA, SellgrenJ, et al. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154: 1490–6.
47. ParatiG, BonsignoreMR, InsalacoG, et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997; 15: 1621–6.
48. KapurVK, ResnickHE, GottliebDJ. Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association?Sleep 2008; 31: 1127–32.
49. BarbeF, MayoralasLR, DuranJ, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 2001; 134: 1015–23.
50. RobinsonGV, SmithDM, LangfordBA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006; 27: 1229–35.
51. MarroneO, LombardiC, ParatiG. Effects of continuous positive airway pressure therapy on hypertension control in patients with sleep-related breathing disorders: available evidence and unresolved issues. J Hypertens 2010; 28: 2012–15.
52. BarbeF, Duran-CantollaJ, CapoteF, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718–26.
53. VernetC, RedolfiS, AttaliV, et al. Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms. Eur Respir J 2011; 38: 98–105.
54. VernetC, RedolfiS, AttaliV, et al. Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment. Eur Respir J 2012; 39: 227–8.
55. IpMS, TseHF, LamB, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348–53.
56. VgontzasAN, PapanicolaouDA, BixlerEO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151–8.
57. BoströmKB, HednerJ, MelanderO, et al. Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 2007; 25: 779–83.